GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Enzymotec Ltd (NAS:ENZY) » Definitions » Additional Paid-In Capital

Enzymotec (Enzymotec) Additional Paid-In Capital : $132.15 Mil(As of Sep. 2017)


View and export this data going back to 2013. Start your Free Trial

What is Enzymotec Additional Paid-In Capital?


Enzymotec's quarterly additional paid-in capital increased from Mar. 2017 ($127.80 Mil) to Jun. 2017 ($128.66 Mil) and increased from Jun. 2017 ($128.66 Mil) to Sep. 2017 ($132.15 Mil).

Enzymotec's annual additional paid-in capital increased from Dec. 2014 ($122.08 Mil) to Dec. 2015 ($124.24 Mil) and increased from Dec. 2015 ($124.24 Mil) to Dec. 2016 ($127.01 Mil).

Enzymotec Additional Paid-In Capital Historical Data

The historical data trend for Enzymotec's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Enzymotec Additional Paid-In Capital Chart

Enzymotec Annual Data
Trend Dec11 Dec12 Dec13 Dec14 Dec15 Dec16
Additional Paid-In Capital
Get a 7-Day Free Trial 47.45 119.55 122.08 124.24 127.01

Enzymotec Quarterly Data
Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 126.36 127.01 127.80 128.66 132.15

Enzymotec Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Enzymotec Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Enzymotec's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Enzymotec (Enzymotec) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Enzymotec Ltd (NAS:ENZY) » Definitions » Additional Paid-In Capital
Comparable Companies
WAR:MAB XKRX:087010 ACRS MRNS DOVA IMDZ LSE:ARIX TSE:2395 EVLO MCRB HARP KOD KALA SZSE:000004 ABVC CDMO XERS MNKD SBBP OSL:NANO
Traded in Other Exchanges
N/A
Address
Website
http://www.enzymotec.com
Enzymotec Ltd is nutritional and food ingredients company. It develops and manufactures nutritional ingredients and medical foods based on proprietary technologies. Its product portfolio includes Infat, K-Real, Enzy PS solutions, Vayacog, Vayarin and Vayaroll. The company has Nutrition and Vaya Pharma reportable segments. It derives majority of its revenues from Nutrition segment. The firm mainly operates in America, Europe, Australia, Asia, and Israel.

Enzymotec (Enzymotec) Headlines

From GuruFocus

Julian Robertson Adds to Multiple Positions in 3rd quarter

By Tiziano Frateschi Tiziano Frateschi • 12-20-2016

Julian Robertson Cuts Half of Stake in Paulson-Backed Company

By Holly LaFon Holly LaFon • 07-01-2016

Tiger Management Founder Julian Robertson Ups Stake in Enzymotec

By Kyle Ferguson Kyle Ferguson • 12-07-2015